K Nomiyama

1.2k total citations · 1 hit paper
20 papers, 947 citations indexed

About

K Nomiyama is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K Nomiyama has authored 20 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Hepatology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K Nomiyama's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). K Nomiyama is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Disease and Transplantation (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). K Nomiyama collaborates with scholars based in Japan. K Nomiyama's co-authors include Susumu Ohmori, Takao Ohmura, Yutaka Kiyohara, Tadamasa Yoshitake, Hidetoshi Iwamoto, M. Fujishima, Isao Kato, Hiroaki Kawano, Keisuke Ueda and Kenji Sueishi and has published in prestigious journals such as Neurology, Journal of Clinical Epidemiology and Diabetologia.

In The Last Decade

K Nomiyama

20 papers receiving 905 citations

Hit Papers

Incidence and risk factors of vascular dementia and Alzhe... 1995 2026 2005 2015 1995 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Nomiyama Japan 8 394 308 179 168 152 20 947
M. Fujishima Japan 9 394 1.0× 334 1.1× 202 1.1× 109 0.6× 148 1.0× 13 1.1k
Tali Cukierman Israel 8 269 0.7× 261 0.8× 198 1.1× 501 3.0× 178 1.2× 10 1.3k
Annelies W. E. Weverling‐Rijnsburger Netherlands 14 208 0.5× 278 0.9× 118 0.7× 240 1.4× 214 1.4× 15 1.1k
P. McGovern United States 5 308 0.8× 222 0.7× 152 0.8× 88 0.5× 270 1.8× 7 985
F. Maioli Italy 20 245 0.6× 300 1.0× 79 0.4× 187 1.1× 120 0.8× 48 1.1k
Satu Ahtiluoto Finland 11 313 0.8× 359 1.2× 165 0.9× 145 0.9× 87 0.6× 18 953
Paula Kivinen Finland 15 202 0.5× 502 1.6× 79 0.4× 208 1.2× 165 1.1× 18 1.3k
Kenji Wada Japan 9 186 0.5× 197 0.6× 84 0.5× 71 0.4× 217 1.4× 19 1.0k
Aozhou Wu United States 14 246 0.6× 200 0.6× 130 0.7× 125 0.7× 227 1.5× 45 1.0k
Lewis Kuller United States 7 208 0.5× 264 0.9× 182 1.0× 69 0.4× 66 0.4× 10 926

Countries citing papers authored by K Nomiyama

Since Specialization
Citations

This map shows the geographic impact of K Nomiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Nomiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Nomiyama more than expected).

Fields of papers citing papers by K Nomiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Nomiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Nomiyama. The network helps show where K Nomiyama may publish in the future.

Co-authorship network of co-authors of K Nomiyama

This figure shows the co-authorship network connecting the top 25 collaborators of K Nomiyama. A scholar is included among the top collaborators of K Nomiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Nomiyama. K Nomiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nomiyama, K, et al.. (1998). Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.. PubMed. 89(8). 232–7. 1 indexed citations
2.
Nomiyama, K, et al.. (1997). [Partial splenic embolization for the treatment of liver cirrhosis with hypersplenism: assessment of clinical response and liver function].. PubMed. 94(8). 526–31. 7 indexed citations
3.
Ogata, Hisanobu, et al.. (1997). Fatty liver in a case with heterozygous familial hypobetalipoproteinemia.. PubMed. 92(2). 339–42. 25 indexed citations
4.
Nomiyama, K, Kazuo Ueda, Yutaka Kiyohara, et al.. (1996). Malignant neoplasms in the Japanese community of Hisayama: Mortality and changing pattern during a 30-year observation period based on a consecutive autopsy series. Journal of Clinical Epidemiology. 49(1). 45–50. 3 indexed citations
5.
Yoshitake, Tadamasa, Yutaka Kiyohara, Isao Kato, et al.. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population. Neurology. 45(6). 1161–1168. 650 indexed citations breakdown →
6.
Ohmura, Takao, Kazuo Ueda, Yutaka Kiyohara, et al.. (1994). The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia. 37(9). 897–904. 35 indexed citations
7.
Iwamoto, Hidetoshi, Yutaka Kiyohara, Isao Kato, et al.. (1994). Mortality from Major Causes of Death and its Risk Factors in the Elderly. 26-year Follow-up Study in Hisayama.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 31(9). 671–676. 4 indexed citations
8.
Hasuo, Yutaka, M Fujishima, Takumi Ohmura, et al.. (1994). The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia. 37(9). 897–904. 7 indexed citations
9.
Ohmori, Susumu, Yutaka Kiyohara, Isao Kato, et al.. (1994). Hyperinsulinaemia and blood pressure in a general Japanese population. Journal of Hypertension. 12(10). 1191???1998–1191???1998. 28 indexed citations
10.
Ohmura, Takao, Kazuo Ueda, Yutaka Kiyohara, et al.. (1993). The Impact of Glucose Intolerance on Stroke Incidence in a 22-Year Follow-Up Study of the General Population, the Hisayama Study. 36(1). 17–24. 8 indexed citations
11.
Ohmura, Takao, Kazuo Ueda, Yutaka Kiyohara, et al.. (1993). Prevalence of Type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia. 36(11). 1198–1203. 156 indexed citations
12.
Tsuji, Hiroshi, K Ikeda, K Nomiyama, & M Fujishima. (1993). [Effects of treatment with rice bran fiber and cholestyramine on clinical and laboratory findings in Yusho patients].. PubMed. 84(5). 282–6. 3 indexed citations
13.
Tsuji, Hiroshi, et al.. (1992). Comparison of the properties of ribonucleases in human liver tissue and serum.. PubMed. 30(6). 339–41. 1 indexed citations
14.
Ibayashi, Setsuro, et al.. (1992). Marked reduction of cerebral oxygen metabolism in patients with advanced cirrhosis: a positron emission tomography study.. PubMed. 83(1). 33–42. 2 indexed citations
15.
Tsuji, Hiroshi, et al.. (1991). [A case of liver cirrhosis associated with chronic subdural hematoma and hepatic encephalopathy].. PubMed. 82(10). 528–32. 4 indexed citations
16.
Nomiyama, K, et al.. (1991). [Positron emission tomography (PET) before and after treatment of hyperammonemia in a patient with decompensated liver cirrhosis].. PubMed. 82(10). 521–7. 2 indexed citations
17.
Nomiyama, K, et al.. (1991). [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].. PubMed. 82(3). 105–9. 2 indexed citations
18.
Tsuji, Hiroshi, et al.. (1991). [Effects of rice bran fiber and cholestyramine on peripheral blood cells and biochemical parameters in Yusho].. PubMed. 82(5). 330–4. 1 indexed citations
19.
Tsuji, Hiroshi, K Nomiyama, Hidenori Watanabe, et al.. (1987). Primary biliary cirrhosis in two sisters.. Nihon Naika Gakkai Zasshi. 76(4). 522–527. 1 indexed citations
20.
Nomiyama, K, Hiroko Nomiyama, & Hiroshi Matsui. (1971). Prevalence of 1-antitrypsin deficiency in Japan.. PubMed. 45(2). 253–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026